Kiran Mazumdar-Shaw is a first-generation entrepreneur and global business

leader with over 4 decades of experience in biotechnology. Fueled by her passion,

she started her biotech journey in 1978 from her garage in India . and
spearheaded its evolution from an industrial enzymes manufacturing company to
a fully integrated Bio-pharmaceutical company with a well-balanced business
portfolio of products and a research focus on Diabetes, Oncology and Auto-
immune diseases.Today, that journey is changing lives for the better across the
globe. She is regarded as an unconventional thinker with many firsts to her credit.
Under her aegis, Biocon delivers on the promise of making medicines accessible
and affordable to millions of patients worldwide. She also established two
subsidiaries named Syngene in1994 to provide development support services as
an outsourcing firm for discovery research and Clinigenein in 2000 to cater to
clinical development services.

Biocon is an Indian Biopharmaceutical company with products and research

services ranging from preclinical to clinical development through the
commercialization. Biocon was setup in 1978 in the garage of her rented house
in Bangalore with just Rs10,000 in hand. Biocon, India's largest Biotechnology
company focus on delivering affordable innovation. It is committed to reduce
therapy costs of chronic diseases like diabetes, cancer and autoimmune diseases
by leveraging India's cost advantage by delivering affordable healthcare
solutions to patients, partners and healthcare systems across the globe.